Drug intelligence / Profile preview

Utixira

Development stage: Preclinical
Lead developer: SAVA Healthcare
Administration: Oral, Topical

Overview

**Utixira** is an Ayurvedic anti-itch product range marketed by Sava Healthcare for itching and related skin discomfort. Public product information identifies a topical Utixira Anti-Itch Lotion containing zinc oxide and multiple traditional herbal and mineral ingredients, including Garcinia indica, Aloe barbadensis, Tagetes erecta, Tinospora cordifolia, Curcuma longa, Brassica napus, Opuntia ficus-indica, and Mentha arvensis. A Sava-sponsored exploratory clinical study, NCT06924840, is evaluating a regimen of Utixira Lotion plus Utixira Tablet in adults with dry or sensitive skin prone to mild-to-moderate pruritus or urticaria. The molecular targets and pharmacologic mechanism of the overall Utixira range have not been publicly specified. ([1mg.com](https://www.1mg.com/otc/utixira-nti-itch-lotion-otc1042802))

Brand names: Utixira

Beyond the preview

Go deeper on Utixira.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Utixira.

Explore the full profile